ClinicalTrials.govpublic full text
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
prostate cancer, stage i prostate cancer, stage iib prostate cancer, stage iia prostate cancer, stage iii prostate cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800173
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.